Bulgaria Country Drug Report 2018

National drug strategy and coordination

National drug strategy

Adopted by the Council of Ministers in 2014, Bulgaria’s National Anti-Drug Strategy (2014-18), with its associated action plan and financial plan, addresses issues related to illicit drugs. The strategy is built around the pillars of drug demand and drug supply reduction and has three joint activity areas. Its main demand reduction goals are to improve public health and the health and social functioning of individuals; to protect society from drug markets; and to reduce the demand for illicit drugs. In the area of supply reduction, the goals are to reduce the supply of illicit drugs and their precursors; to increase the efficiency of law enforcement and supervisory authorities; to enhance prevention of drug-related crimes; and to ensure effective cooperation using a joint and coordinated approach. In Bulgaria, drug policy and the National Anti-Drug Strategy (2014-18) are evaluated through ongoing indicator monitoring and specific research projects.

#

National coordination mechanisms

The National Drug Council is a body of the Council of Ministers of the Republic of Bulgaria. Operating at inter-ministerial level, it is responsible for the implementation and coordination of illicit drug policy. It is chaired by the Minister of Health and includes representatives from all relevant ministries. The Narcotic Substances Section is part of the Pharmaceutical Products, Medical Devices and Narcotic Substances Directorate of the Ministry of Health. It is responsible for assisting the Minister of Health in controlling scheduled substances for medical purposes and meeting Bulgaria’s obligations under international drug control treaties. The National Centre for Addictions houses the national focal point for the EMCDDA and is responsible for the collection and analysis of a range of drug-related data. Local-level coordination is undertaken by 27 municipal drug councils and 27 prevention and information centres.


Bulgaria main page

Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.